The Vanguard Group Discloses Position in Spire Healthcare

The Vanguard Group, Inc. has filed a Form 8.3 disclosure regarding its interests in Spire Healthcare Group plc. As of October 30, 2026, Vanguard holds a 3.58% stake in Spire's ordinary shares, equating to 14,417,641 shares. The transaction involved a purchase of 4,004 shares at 2.49 GBP per share.

This disclosure complies with Rule 8.3 of the Takeover Code, which mandates transparency from parties owning 1% or more of relevant securities in a company subject to an offer. Vanguard has clarified that there are no existing agreements or understandings involving indemnities or further dealings beyond this disclosure. No Supplemental Form 8 was attached, indicating a straightforward position without additional open derivatives or agreements.

The full disclosure and further information is facilitated through The Panel's Market Surveillance Unit.